Jane Street
FHTX icon

Jane Street’s Foghorn Therapeutics FHTX Stock Holding History

Jane Street’s Portfolio FHTX Stock Details FHTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-132,501
Closed -$716K – 11988
2025
Q4 		$716K Buy
132,501
+66,112
+100% +$300K ﹤0.01% 6902
2025
Q3 		$325K Buy
66,389
+44,767
+207% +$237K ﹤0.01% 8743
2025
Q2 		$102K Buy
+21,622
New +$90.4K ﹤0.01% 8946
2024
Q4 		– Sell
-18,547
Closed -$173K – 9747
2024
Q3 		$173K Sell
18,547
-15,580
-46% -$113K ﹤0.01% 8739
2024
Q2 		$196K Buy
+34,127
New +$203K ﹤0.01% 8398
2024
Q1 		– Sell
-12,851
Closed -$82.9K – 9451
2023
Q4 		$82.9K Buy
+12,851
New +$55.4K ﹤0.01% 8655
2022
Q1 		– Sell
-46,638
Closed -$1.07M – 10493
2021
Q4 		$1.07M Buy
+46,638
New +$670K ﹤0.01% 5764

Other funds holding FHTX

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Jane Street's FHTX Position: Q1 2026 in Review

Jane Street sold out of Foghorn Therapeutics (FHTX) in Q1 2026, closing a stake of 132,501 shares — an estimated $716K sold.

Jane Street first reported a position in FHTX in Q4 2021 and held it in 7 quarters. The position peaked at $1.07M in Q4 2021. 105 funds tracked by Wall St. Rank hold FHTX as of Q1 2026.

  • Jane Street reported no remaining Foghorn Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 132,501 Foghorn Therapeutics shares in Q1 2026, an estimated $716K.
  • Jane Street first reported a position in Foghorn Therapeutics in Q4 2021 and held it in 7 quarters.
  • Jane Street's Foghorn Therapeutics position peaked at $1.07M in Q4 2021.
  • 105 funds tracked by Wall St. Rank held Foghorn Therapeutics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.